The future of cancer therapy: selecting patients likely to respond to PD1/L1 blockade.
作者:
Ribas(Antoni),Tumeh(Paul C)
状态:
发布时间2014-10-02
, 更新时间 2016-10-19
期刊:
Clin Cancer Res
摘要:
It is conceivable that, in the near future, an assay that defines the likelihood of a patient with advanced cancer to respond to immunotherapy based on PD1/L1 blockade will be the initial decision point to select the treatment of patients with any cancer type.